Personal information

Countries

Germany

Activities

Collapse all

Works (4)

Multiparametric MRI for characterization of the tumour microenvironment

Nature Reviews Clinical Oncology
2024-06 | Journal article
DOI: 10.1038/s41571-024-00891-1
Contributors: Emily Hoffmann; Max Masthoff; Wolfgang G. Kunz; Max Seidensticker; Stefanie Bobe; Mirjam Gerwing; Wolfgang E. Berdel; Christoph Schliemann; Cornelius Faber; Moritz Wildgruber
Source: check_circle
Crossref

Prevalence and clinical impact of CD56 and T‐cell marker expression in acute myeloid leukaemia: A single‐centre retrospective analysis

eJHaem
2024-02 | Journal article
DOI: 10.1002/jha2.827
Contributors: Inna Shaforostova; Simon Call; Georg Evers; Christian Reicherts; Linus Angenendt; Matthias Stelljes; Wolfgang E. Berdel; Alexander Pohlmann; Jan‐Henrik Mikesch; Frank Rosenbauer et al.
Source: check_circle
Crossref

Activation of Investigator-Initiated Clinical Trials with a Pharmaceutical for Cancer Patients before and after Post-Millennial Changes of Regulations in Germany and Europe

Cancers
2022-03-03 | Journal article
DOI: 10.3390/cancers14051308
Contributors: Wolfgang E. Berdel
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML

Blood Advances
2021-11-09 | Journal article
DOI: 10.1182/bloodadvances.2021005236
Contributors: Linus Angenendt; Marius Wöste; Jan-Henrik Mikesch; Maria Francisca Arteaga; Adrian Angenendt; Sarah Sandmann; Wolfgang E. Berdel; Georg Lenz; Martin Dugas; Soheil Meshinchi et al.
Source: check_circle
Crossref
How many people are using ORCID?